PKG Health
PKG Health develops the FDA-cleared PKG wearable and proprietary AI algorithms for continuous, objective monitoring of Parkinson's disease and other movement disorders, serving neurologists, the NHS, US Veterans Affairs, and life sciences clinical trial sponsors globally.
- Company typePrivate
- Founded2007
- HeadquartersMelbourne, Australia
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What PKG Health does
PKG Health, formerly Global Kinetics Corporation, is an Australia-based medical device and digital health company founded in 2007 that develops the PKG (Personal KinetiGraph) system for continuous, objective monitoring of neurological movement disorders, primarily Parkinson's disease. The system pairs a wrist-worn accelerometer (PKG Watch, 7-10 day battery life) with proprietary FDA Class II cleared, CE-marked, and TGA-approved algorithms that quantify bradykinesia, dyskinesia, tremor, fluctuations, gait, wearing-off, and medication compliance, processing 4,300+ motor and non-motor data points per patient weekly. An HCP Portal provides longitudinal analytics to clinicians, complemented by iOS/Android patient and caregiver apps and a Clinical Trial Services offering that supplies objective digital endpoints to life sciences sponsors and CROs (deployed across 70+ clinical studies). The company operates through hardware sales, recurring subscriptions, and professional services, serving NHS (UK), Valley Parkinson Clinic, US Veterans Affairs, and other neurology providers across Australia, the US, UK, EU, and the Middle East. In October 2025, PKG Health was acquired by Empatica.
PKG Health firmographics
Firmographics- Name
- PKG Health
- Legal name
- Global Kinetics Pty Ltd
- Website
- https://pkghealth.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- PKG Health develops the FDA-cleared PKG wearable and proprietary AI algorithms for continuous, objective monitoring of Parkinson's disease and other movement disorders, serving neurologists, the NHS, US Veterans Affairs, and life sciences clinical trial sponsors globally.
- Ownership category
- akta.pro rank
PKG Health industry classification
Industry- Product category
- Neurological Wearable Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)
Keywords
Where PKG Health is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices4 records
Markets served
PKG Health business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- PKG Wearable Device Sales: Sale of proprietary PKG Watch wearable device to healthcare providers and patients for continuous movement disorder monitoring.
- Clinical Care Platform Subscription: Subscription-based access to HCP portal with advanced analytics, patient management, and reporting capabilities for clinical care.
- Clinical Trial Services (CTS): Services for life sciences sponsors and CROs including objective motor symptom capture, patient-reported outcomes, white-labeled apps, and digital endpoints for clinical trials. Technology deployed in over 70 clinical studies globally.
- PKG Pearl Premium Subscription: Mobile and web application offering premium features for patients, caregivers, and healthcare professionals with subscription fees billed on monthly or annual basis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | PKG Pearl Free Tier |
| Subscription | Monthly | PKG Pearl Premium |
Go-to-market motion1 record
Distribution channels5 records
Marketing channels4 records
PKG Health product offering
Product offeringCore offering
PKG Health designs, manufactures and sells the PKG (Personal KinetiGraph) System, an FDA Class II cleared wearable platform for continuous objective monitoring of Parkinson's disease and other movement disorders. The system combines a wrist-worn PKG Watch accelerometer, proprietary AI/ML movement-disorder algorithms, and an HCP Portal for clinician reporting, and is complemented by patient/caregiver mobile apps, Clinical Trial Services for life sciences sponsors, and Digital Therapeutics companion apps.
Product overview
PKG Health offers the PKG® System (Personal KinetiGraph/Parkinson's KinetiGraph), a comprehensive FDA-cleared, CE-marked, TGA-approved platform for continuous objective assessment of movement disorders in Parkinson's disease. The system comprises three core components: (1) the PKG Watch wearable device with up to 10-day battery life for continuous movement recording, (2) proprietary AI/ML algorithms for quantifying bradykinesia, dyskinesia, tremor, fluctuations, and other motor symptoms, and (3) the HCP Portal with longitudinal analytics for treatment guidance. Supporting offerings include Patient and Caregiver Apps (iOS/Android), Clinical Trial Services (CTS) for life sciences sponsors, and Digital Therapeutics (DTx) for brand optimization. PKG Pearl is a separate mobile/web application for UK patients focused on treatment management and tracking. PKG Health was acquired by Empatica in October 2025.
Differentiator
Problem solved
Functional benefit
Brands
- PKG (Personal KinetiGraph): Wearable movement disorder monitoring system for Parkinson's disease patients, providing continuous objective assessment of movement disorder symptoms including tremor, dyskinesia, and bradykinesia.
- PKG Pearl
- KinetiGraph
Products and services
- PKG System (Personal KinetiGraph) Integrated FDA Class II cleared wearable monitoring system for continuous objective assessment of movement disorders in Parkinson's disease, combining the PKG Watch accelerometer, proprietary AI/ML algorithms and HCP Portal reporting. Sold to neurologists, movement disorder specialists, hospitals and health systems.
- Patient and Caregiver Apps iOS and Android mobile applications that let Parkinson's patients and caregivers log symptoms, track medication adherence and share contextual data with their healthcare providers alongside the PKG System.
- Clinical Trial Services (CTS) Service offering that deploys the PKG Watch and analytics platform in pharmaceutical and biotech clinical trials to capture objective digital endpoints for bradykinesia, dyskinesia and tremor. Used by life sciences sponsors and CROs in late-phase and pivotal studies.
- Digital Therapeutics (DTx) Companion Apps White-labeled Digital Therapeutics companion apps built for life sciences partners to support patient engagement, adherence and therapy programs alongside the PKG platform.
- PKG Pearl App Free UK patient-facing mobile app for people with Parkinson's and their caregivers that provides medication reminders, symptom logging, educational content and connection to healthcare providers via the HCP Portal.
- PKG Watch (Gen 3.0 / PKG4) Third-generation wrist-worn accelerometer device worn by Parkinson's patients for up to 10 days to continuously record movement data that feeds the PKG algorithms and reports.
Quantifiable outcome
- 100% improvement in MDS-UPDRS score using PKG vs. standard of care
- +5 more outcomes
Companies that use PKG Health
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles4 records
PKG Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
PKG Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- EmpaticacoreEmpatica acquired PKG Health in October 2025 to strengthen its AI wearable monitoring technology and expand capabilities in clinical care and neurology research. The acquisition integrated PKG Health's movement disorder algorithms and digital endpoints into Empatica's AI-enabled health monitoring wearables for Parkinson's disease.
Scale indicators8 records
Recent moves5 records
Expansion highlights6 records
PKG Health competitors and assessment
Company assessmentEmerging players
- Cionic: Neural sleeve wearable startup focused on mobility impairment from MS, stroke, and cerebral palsy. Comparable emerging wearable player in the neuro-rehabilitation monitoring category, with similar B2B2C go-to-market via clinics and payers.
- OpenBCI: Open-source brain-computer-interface and wearable EEG/neural sensing company (Galea, Cyton). Adjacent emerging player in neurological wearable sensing, with overlapping interest in objective neurological measurement for research and consumer applications.
- MindMaze: Swiss neuro-rehabilitation platform combining wearable sensors with gamified digital therapeutics for stroke, Parkinson's, and MS recovery. Comparable emerging player pursuing the same neurological monitoring plus digital therapeutic combo positioning that PKG and PKG Pearl target.
Broad incumbents
- Abbott: Broad neuromodulation incumbent offering the Infinity DBS system for Parkinson's and essential tremor, with growing digital monitoring capabilities. Comparable to PKG in serving movement-disorder specialists and pharma endpoints in DBS-implanted populations.
- Medtronic: Global medtech incumbent providing deep brain stimulation (Activa, Percept PC) for Parkinson's and a partner/competitor in objective PD motor data via the Percept PC brain-sense platform. Differs from PKG by anchoring therapy rather than monitoring, but increasingly overlaps in PD digital endpoint capture.
- Boston Scientific: Diversified neurotechnology incumbent with the Vercise DBS system for Parkinson's and essential tremor, plus the ImageReady MRI-conditional labeling and increasingly integrated digital tools. Serves the same movement-disorder specialist channel and competes for clinical-trial data partnerships.
- iRhythm Technologies: Public wearable cardiac-monitoring company (Zio) that pioneered patch-based biosensor monitoring with FDA clearance and a clinical evidence library. A broad incumbent analogue to PKG in the connected-health-wearable-as-regulated-biosensor category, though dedicated to cardiac arrhythmia rather than movement disorders.
Direct peers
- Great Lakes NeuroTechnologies: US-based developer of movement-disorder assessment technology including Kinesia and Kinesia One (wearable sensors with clinical scoring algorithms for tremor, dyskinesia, bradykinesia). Direct competitor to PKG in objective Parkinson's motor symptom monitoring for both clinical care and pharma trials.
- Rune Labs: San Francisco-based StrivePD platform that combines Apple Watch data with deep brain stimulation (DBS) and Medtronic Percept device integration for Parkinson's patients. A direct peer in PD digital monitoring and clinical-trial endpoint generation, though differentiated by consumer-hardware-only model vs PKG's proprietary wearable.
- ActiGraph: Manufacturer of FDA-cleared wearable actigraphy monitors (CentrePoint Insight Watch) widely deployed as digital endpoints in pharmaceutical clinical trials. Comparable to PKG's CTS offering across neuroscience, sleep, and rare-disease trials where objective activity data is required.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
PKG Health social profiles
Digital presencePKG Health compliance and trust
Trust signalCompliance5 records
PKG Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
PKG Health leadership team
Management profileNumber of profiles
PKG Health subsidiaries and ownership
Company hierarchySubsidiaries6 records
PKG Health funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PKG Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PKG Health
What does PKG Health do?
PKG Health designs, manufactures and sells the PKG (Personal KinetiGraph) System, an FDA Class II cleared wearable platform for continuous objective monitoring of Parkinson's disease and other movement disorders. The system combines a wrist-worn PKG Watch accelerometer, proprietary AI/ML movement-disorder algorithms, and an HCP Portal for clinician reporting, and is complemented by patient/caregiver mobile apps, Clinical Trial Services for life sciences sponsors, and Digital Therapeutics companion apps.
Is PKG Health a public or private company?
PKG Health is a private company. It is classified as corporate owned and is currently acquired.
When was PKG Health founded?
PKG Health was founded in 2007. It employs 11 to 50 people.
Where is PKG Health based?
PKG Health is headquartered in Melbourne, Australia, in the Oceania region.
How does PKG Health make money?
Four revenue lines are on record. PKG Wearable Device Sales are the primary driver. The others are clinical Care Platform Subscription, clinical Trial Services (CTS) and PKG Pearl Premium Subscription.
Who are PKG Health's main competitors?
Emerging players on record are Cionic, OpenBCI and MindMaze. Broad incumbents are Abbott, Medtronic, Boston Scientific and iRhythm Technologies. Direct peers are Great Lakes NeuroTechnologies, Rune Labs and ActiGraph.
Does PKG Health have an API?
No public API is recorded for PKG Health.
What industry is PKG Health in?
PKG Health's product category is Neurological Wearable Medical Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAFAJ, Neurology RPM (epilepsy, Parkinson’s, MS monitoring). Its NAICS code is 334510 and its SIC code is 3845.